Correction: Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib

PDF  |  How to cite

Oncotarget. 2019; 10:254-254. https://doi.org/10.18632/oncotarget.26577

Metrics: PDF 1390 views  |   ?  

Bin Zhao1 and Hong Zhao1,2

1 Center for Scientific Research, The Second Affiliated Hospital & Yuying Children’s Hospital, Wenzhou Medical University, Wenzhou, 325027, China
2 Department of Medical Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin, 150081, China

Published: January 04, 2019

This article has been corrected: The correct author affiliation information is given below:

Hong Zhao1,2

Original article: Oncotarget. 2017; 8:93813-93824. DOI: https://doi.org/10.18632/oncotarget.21217.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26577